Immediate Implants With Customized Abutments
Effect of Peri-implant Gap Grafting and Immediate Provisionalization With Customized Healing Abutments on the Stability of Peri-implant Soft Tissues - a Randomized Clinical Trial
1 other identifier
interventional
80
1 country
1
Brief Summary
Tooth extraction is followed by marked alterations of the tissue volume. The resorption process of at least the surrounding mucosa can be altered by using immediate implant placement and additional features such as immediate provisional crown, platform switching and grafting the gap between implant and buccal bone plate. The support of the gingival margin with a provisional crown led to an increase of buccal gingival tissue. Teeth scheduled for extraction will be used to study the effect of a customized healing abutment. The following groups will be randomly assigned: Control: A commercially available healing abutment will be screwed on top of the implant and a collagen sponge will be used to protect the graft. Test: A customized PEEK abutment mimicking the subgingival emergence of the extracted tooth will be screw retained on top of the implant to seal the extraction site.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 10, 2020
CompletedFirst Submitted
Initial submission to the registry
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
December 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 10, 2023
CompletedDecember 6, 2022
November 1, 2022
2 years
November 15, 2022
November 23, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Implant success
Evaluated according to the criteria of Albrektsson et al. (1986): * the implant is immobile when tested clinically * Radiography does not demonstrate evidence of peri-implant radiolucency * Bone loss that is less than 0.2 mm annually after the implant's first year of service * No pain, discomfort or infection
1 year of follow up
Peri-implant marginal bone level- Radiographic Measurements
Peri-implant bone level will be assessed based on individual peri-apical x-rays performed at baseline, after implant placement, at the time of final impression at 90 days and after insertion of the definitive crown after 160 days using an individualized impression tray with resin imprints and at 1, 2, 3 years of follow up. The radiographic measurements will be performed by an independent evaluator, who will be unware of the assigned treatment.
1 year of follow up
Peri-implant marginal bone level- Radiographic Measurements
Peri-implant bone level will be assessed based on individual peri-apical x-rays performed at baseline, after implant placement, at the time of final impression at 90 days and after insertion of the definitive crown after 160 days using an individualized impression tray with resin imprints and at 1, 2, 3 years of follow up. The radiographic measurements will be performed by an independent evaluator, who will be unware of the assigned treatment.
2 years of follow up
Peri-implant marginal bone level- Radiographic Measurements
Peri-implant bone level will be assessed based on individual peri-apical x-rays performed at baseline, after implant placement, at the time of final impression at 90 days and after insertion of the definitive crown after 160 days using an individualized impression tray with resin imprints and at 1, 2, 3 years of follow up. The radiographic measurements will be performed by an independent evaluator, who will be unware of the assigned treatment.
3 years of follow up
Implant success
Evaluated according to the criteria of Albrektsson et al. (1986): * the implant is immobile when tested clinically * Radiography does not demonstrate evidence of peri-implant radiolucency * Bone loss that is less than 0.2 mm annually after the implant's first year of service * No pain, discomfort or infection
2 years of follow up
Implant success
Evaluated according to the criteria of Albrektsson et al. (1986): * the implant is immobile when tested clinically * Radiography does not demonstrate evidence of peri-implant radiolucency * Bone loss that is less than 0.2 mm annually after the implant's first year of service * No pain, discomfort or infection
3 years of follow up
Secondary Outcomes (17)
Changes in mid-facial mucosal recession
1 year of follow up
Changes in mid-facial mucosal recession
2 years of follow up
Changes in mid-facial mucosal recession
3 years of follow up
Changes in papilla height
1 year of follow up
Changes in papilla height
2 years of follow up
- +12 more secondary outcomes
Study Arms (2)
Test group
EXPERIMENTALA customized PEEK abutment mimicking the subgingival emergence of the extraction site will be screw-retained on the implant to seal the extraction site and to support healing of buccal soft tissues.
Control group
ACTIVE COMPARATORA commercially available healing abutment will be screwed on top of the implant and a collagen sponge will be used to protect the graft.
Interventions
Teeth scheduled for extraction will be used to study the effect of a customized healing abutment. All patients should receive prophylactic antibiotic therapy of 2g of amoxicillin (or clindamycin 600mg if allergic to penicillin) 1 hour before the surgery. Implant placed along the lingual/palatal bone plate and the implant platform should be placed at the level of the buccal bone plate. GUIDOR easy-graft CRYSTAL will be used to fill the defect between implant and buccal bone plate, subsequently, a standard healing abutment or a customized healing abutment will be screw-retained on the implants.
Eligibility Criteria
You may qualify if:
- The patient is ≥ 18 years old
- Extraction of single rooted tooth with healthy adjacent teeth (PD\<5mm, no BOP)
- Patient must be able to understand the purpose of the study and to sign the consent form
You may not qualify if:
- Smoking status of more than 10 cigarettes/day
- History of uncontrolled metabolic disorders (e.g. diabetes mellitus)
- History of malignancy, radiotherapy, or chemotherapy
- Pregnant or breast feeding
- History of immunodeficiences
- existence of metabolic bone disease or disease affecting bone healing
- untreated or active periodontitis (BOP and PD\>5mm)
- absence or defects of the buccal bone plate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HUG
Geneva, 1205, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- The participants ant the biostatician will be blinded on the assignment group
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
November 15, 2022
First Posted
December 6, 2022
Study Start
March 10, 2018
Primary Completion
March 10, 2020
Study Completion
March 10, 2023
Last Updated
December 6, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share